These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18848144)

  • 1. The year in non-ST-segment elevation acute coronary syndrome.
    Giugliano RP; Braunwald E
    J Am Coll Cardiol; 2008 Sep; 52(13):1095-103. PubMed ID: 18848144
    [No Abstract]   [Full Text] [Related]  

  • 2. [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes].
    Bassand JP; Hamm CW; Ardissino D; Boersma E; Budaj A; Fernandez-Aviles F; Fox KA; Hasdai D; Ohman EM; Wallentin L; Wijns W;
    Rev Port Cardiol; 2008 Sep; 27(9):1063-143. PubMed ID: 19044176
    [No Abstract]   [Full Text] [Related]  

  • 3. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 4. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 5. Antithrombotic therapy in medically managed patients with non-ST-segment elevation acute coronary syndromes.
    Gurbel PA; Tantry US
    Heart; 2016 Jun; 102(11):882-92. PubMed ID: 26944654
    [No Abstract]   [Full Text] [Related]  

  • 6. Minimizing the risks of anticoagulants and platelet inhibitors.
    Alexander KP; Peterson ED
    Circulation; 2010 May; 121(17):1960-70. PubMed ID: 20439812
    [No Abstract]   [Full Text] [Related]  

  • 7. The year in non-ST-segment elevation acute coronary syndrome.
    Giugliano RP; Braunwald E
    J Am Coll Cardiol; 2010 Dec; 56(25):2126-38. PubMed ID: 21144974
    [No Abstract]   [Full Text] [Related]  

  • 8. Tailored antithrombotic therapy for acute coronary syndromes.
    Fitchett D
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):935-44. PubMed ID: 18666844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes.
    Gutierrez A; Rao SV
    Cleve Clin J Med; 2010 Jun; 77(6):369-79. PubMed ID: 20516248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated ESC Guidelines for managing patients with suspected non-ST-elevation acute coronary syndromes.
    Eur Heart J; 2011 Dec; 32(23):2909-10. PubMed ID: 22135069
    [No Abstract]   [Full Text] [Related]  

  • 11. Rear-view mirror observations on bleeding in acute coronary syndromes.
    Armstrong PW; Welsh RC
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1178-80. PubMed ID: 21087754
    [No Abstract]   [Full Text] [Related]  

  • 12. Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiative.
    Spinler SA; Ou FS; Roe MT; Gibler WB; Ohman EM; Pollack CV; Alexander KP; Peterson ED
    Pharmacotherapy; 2009 Jun; 29(6):631-8. PubMed ID: 19476416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of prasugrel compared with clopidogrel in patients with acute coronary syndromes: results of TRITON-TIMI 38 trials.
    Mariani M; Mariani G; De Servi S
    Expert Rev Cardiovasc Ther; 2009 Jan; 7(1):17-23. PubMed ID: 19105763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral antiplatelet therapy in unstable angina/non-ST-segment elevation myocardial infarction, ST-segment elevation myocardial infarction, and percutaneous coronary intervention: is it time for a guideline update?
    Saucedo JF
    Am J Cardiol; 2009 Sep; 104(5 Suppl):4C-8C. PubMed ID: 19695354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approaches.
    Subherwal S; Ohman EM; Mahaffey KW; Rao SV; Alexander JH; Wang TY; Alexander KP; Hasselblad V; Roe MT
    Am Heart J; 2013 May; 165(5):644-54, 654.e1. PubMed ID: 23622901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of adjunctive anticoagulants in patients with acute coronary syndrome transitioning to percutaneous coronary intervention.
    Cohen M; Hoekstra J
    Am J Emerg Med; 2008 Oct; 26(8):932-41. PubMed ID: 18926355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The score is in but is the decision final?
    Brinker J
    J Am Coll Cardiol; 2010 Jun; 55(23):2567-9. PubMed ID: 20513596
    [No Abstract]   [Full Text] [Related]  

  • 18. [ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)].
    Hamm CW; Bassand JP; Agewall S; Bax J; Boersma E; Bueno H; Caso P; Dudek D; Gielen S; Huber K; Ohman M; Petrie MC; Sonntag F; Uva MS; Storey RF; Wijns W; Zahger D;
    G Ital Cardiol (Rome); 2012 Mar; 13(3):171-228. PubMed ID: 22395108
    [No Abstract]   [Full Text] [Related]  

  • 19. Comments on the ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.
    ; Fernández-Ortiz A; Pan M; Alfonso F; Arós F; Barrabés JA; Bodí V; Cequiera A; García-Moll X; Jiménez-Candil J; López-Palop R; Peña C; Worner F; ; Alonso Gómez AM; Anguita M; Cequier A; Comín J; Fernández-Ortiz A; Pan M; Worner F; Alonso J; Bardají A; Barón-Esquivias G; Bover R; Angel-Ferrer J; Goicolea J; Gómez-Doblas JJ; Iñiguez A; Mainar V; Marín F; Pedreira M; Roldán I; Sabaté M; Sánchez PL; Sanchis J
    Rev Esp Cardiol (Engl Ed); 2012 Feb; 65(2):125-30. PubMed ID: 22265200
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiplatelet therapy: anti-ischemic benefits versus bleeding risk.
    Gibson CM
    J Interv Cardiol; 2008 Dec; 21 Suppl 1():S3-9. PubMed ID: 19090934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.